Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases

被引：6
作者：
Jung, K [1 ]
机构：
[1] Humboldt Univ, Univ Hosp Charite, Dept Urol, Div Res, D-10098 Berlin, Germany
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2006年 / 44卷 / 04期
关键词：
matrix metalloproteinases; plasma; preanalytical impact; sample processing; serum;
D O I：
10.1515/CCLM.2006.082
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：500 / 502
页数：3
相关论文
共 13 条
[1]   Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood [J].
Alby, C ;
Ben Abdesselam, O ;
Foglietti, MJ ;
Beaudeux, JL .
CLINICA CHIMICA ACTA, 2002, 325 (1-2) :183-186
[2]   Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities [J].
Gerlach, RF ;
Uzuelli, JA ;
Souza-Tarla, CD ;
Tanus-Santos, JE .
ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) :147-149
[3]  
Jung K, 1998, CLIN CHEM, V44, P1060
[4]  
Jung K, 1996, CLIN CHEM, V42, P2043
[5]   Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood [J].
Jung, K ;
Lein, M ;
Laube, C ;
Lichtinghagen, R .
CLINICA CHIMICA ACTA, 2001, 314 (1-2) :241-244
[6]   Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma [J].
Makowski, GS ;
Ramsby, ML .
ANALYTICAL BIOCHEMISTRY, 2003, 322 (02) :283-286
[7]   Effects of blood collection methods on gelatin zymography of matrix metalloproteinases [J].
Mannello, F .
CLINICAL CHEMISTRY, 2003, 49 (02) :339-340
[8]   Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases [J].
Mannello, F ;
Luchetti, F ;
Canonico, B ;
Papa, S .
CLINICAL CHEMISTRY, 2003, 49 (11) :1956-1957
[9]   Concentrations of circulating gelatinases (Matrix metalloproteinase-2 and-9) are dependent on the conditions of blood collection [J].
Meisser, A ;
Cohen, M ;
Bischof, P .
CLINICAL CHEMISTRY, 2005, 51 (01) :274-276
[10]   Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease [J].
Sfiridaki, A ;
Miyakis, S ;
Tsirakis, G ;
Alegakis, A ;
Passam, AM ;
Kandidaki, E ;
Margioris, AN ;
Alexandrakis, MG .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (09) :934-938
12